Figure 2.
Figure 2. The disease-free survival and overall survival of prognostically different three subgroups of CD34>7% andFLT3-ITD, CD34>7%or FLT3-ITD and CD34¡Ü7% and FLT3-WT in entire patients with NPM1-mutation(A and B)

The disease-free survival and overall survival of prognostically different three subgroups of CD34>7% andFLT3-ITD, CD34>7%or FLT3-ITD and CD34¡Ü7% and FLT3-WT in entire patients with NPM1-mutation(A and B)

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal